Seeing Is Believing
Currently out of the existing stock ratings of Joseph Schwartz, 46 are a HOLD (19.09%), 189 are a BUY (78.42%), 6 are a SELL (2.49%).
Analyst Joseph Schwartz, currently employed at LEERINK, carries an average stock price target met ratio of 53.32% that have a potential upside of 44% achieved within 296 days.
Joseph Schwartz’s has documented 484 price targets and ratings displayed on 44 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ANTX, AN2 Therapeutics at 03-Jul-2024.
Analyst best performing recommendations are on LRMR (LARIMAR THERAPEUTICS).
The best stock recommendation documented was for LRMR (LARIMAR THERAPEUTICS) at 12/1/2015. The price target of $132 was fulfilled within 1 day with a profit of $59.16 (30.95%) receiving and performance score of 309.48.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
13.75
14
3 years 9 months 21 days ago
13/18 (72.22%)
$0.67 (5.12%)
50
Buy
13.75
14
3 years 9 months 24 days ago
5/7 (71.43%)
$0.01 (0.07%)
130
Hold
10
$-3.75 (-27.27%)
13
3 years 11 months 8 days ago
6/8 (75%)
$-0.63 (-5.93%)
126
Buy
10
$-3.75 (-27.27%)
14
3 years 11 months 8 days ago
1/5 (20%)
$-0.63 (-5.93%)
6
Hold
3 years 11 months 19 days ago
0/3 (0%)
$17.19 (61.81%)
Which stock is Joseph Schwartz is most bullish on?
Which stock is Joseph Schwartz is most reserved on?
What Year was the first public recommendation made by Joseph Schwartz?